Growth Metrics

Ultragenyx Pharmaceutical (RARE) Operating Income Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.69%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -347.04%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 80.62%
7 Evaxion A 62.56 Bn 62.54 Bn - 1.27%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,386.07%
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn -18.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18.18%
Dec 31, 2025 7.38%
Sep 30, 2025 -29.47%
Jun 30, 2025 7.28%
Mar 31, 2025 13.52%
Dec 31, 2024 -0.38%
Sep 30, 2024 9.04%
Jun 30, 2024 21.35%
Mar 31, 2024 -7.30%
Dec 31, 2023 16.33%
Sep 30, 2023 35.53%
Jun 30, 2023 -4.49%
Mar 31, 2023 -12.79%
Dec 31, 2022 -41.99%
Sep 30, 2022 -150.55%
Jun 30, 2022 -71.06%
Mar 31, 2022 -28.21%
Dec 31, 2021 -6.75%
Sep 30, 2021 -78.53%
Jun 30, 2021 -31.28%
Mar 31, 2021 11.68%
Dec 31, 2020 -1.72%
Sep 30, 2020 57.37%
Jun 30, 2020 43.94%
Mar 31, 2020 -21.62%
Dec 31, 2019 -4.55%
Sep 30, 2019 -31.67%
Jun 30, 2019 -18.52%
Mar 31, 2019 -2.83%
Dec 31, 2018 6.71%
Sep 30, 2018 -7.09%
Jun 30, 2018 -20.98%
Mar 31, 2018 -37.93%
Dec 31, 2017 -37.26%
Sep 30, 2017 -27.26%
Jun 30, 2017 -35.12%
Mar 31, 2017 -30.46%
Dec 31, 2016 -25.63%
Sep 30, 2016 -64.72%
Jun 30, 2016 -92.60%
Mar 31, 2016 -149.38%
Dec 31, 2015 -231.45%
Sep 30, 2015 -152.20%
Jun 30, 2015 -120.64%
Mar 31, 2015 -107.97%
Dec 31, 2014 -77.88%
Sep 30, 2014 -104.03%
Jun 30, 2014 -65.65%
Mar 31, 2014 -53.24%